期刊文献+

慢性乙型肝炎患者红细胞参数和血小板参数检测的临床意义 被引量:2

Clinical significance of detecting erythrocyte parameter and platelet parameter in patients with chronic hepatitis B
暂未订购
导出
摘要 目的探讨慢性乙型肝炎患者红细胞参数和血小板参数检测的临床意义。方法对89例慢性乙型肝炎患者的临床资料进行回顾性分析,选择50例健康体检者为对照组,比较两组红细胞参数和血小板参数。结果慢性乙型肝炎中度患者红细胞参数和血小板参数与对照组比较,差异有统计学意义(P<0.05);慢性乙型肝炎重度患者与对照组比较,差异也有统计学意义(P<0.01)。慢性乙型肝炎重度患者红细胞参数和血小板参数异常检出率>中度患者>轻度患者。结论红细胞参数和血小板参数的改变可反映慢性乙型肝炎病情轻重和肝脏损害程度。 Objective To investigate the clinical significance of detecting erythrocyte parameter and platelet parameter in patients with chronic hepatitis B. Methods The clinical data of 89 cases of chronic hepatitis B patients were retrospectively analyzed, 50 cases of healthy people were selected as control group, erythrocyte parameter and platelet parameter of two groups were compared. Results The erythrocyte parameter and platelet parameter in moderate chronic hepatitis B patients were compared with that of control group, the difference was statistically significant (P 〈 0.05). Comparison between severe chronic hepatitis B patients and control group showed a significant difference (P 〈 0.01). The detectable rates of abnormal erythrocyte parameter and platelet parameter in chronic hepatitis B patients ranked as severe 〉 moderate 〉 mild. Conclusion The change of erythrocyte parameter and platelet parameter can reflect the severity of chronic hepatitis B and the degree of liver damage.
作者 张莉
出处 《中国当代医药》 2013年第6期59-60,共2页 China Modern Medicine
关键词 慢性乙型肝炎 红细胞参数 血小板参数 临床意义 Chronic hepatitis B Erythrocyte parameter Platelet parameter Clinical significance
  • 相关文献

参考文献6

二级参考文献34

  • 1蒋孝华,谢玉桃,谭德明.病毒性肝炎血小板减少症影响因素的研究[J].中华肝脏病杂志,2004,12(12):734-736. 被引量:18
  • 2马艳丽,任万华.病毒性肝炎血小板减少机制探讨[J].胃肠病学和肝病学杂志,2005,14(3):315-317. 被引量:29
  • 3林果为.病毒性肝炎相关性再生障碍性贫血[J].中华内科杂志,1994,33(9):581-582. 被引量:16
  • 4中华医学会肝病学分会、感染病学分会.慢性乙型肝炎防治指南[J].中华肝脏病杂志,2005,13(12):881-891. 被引量:1957
  • 5Goulis J, Chau TN, Jordan S, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia and are restored after orthotopic liver transplantation [J]. Gut, 1999, 44(5):754-758.
  • 6Schoffski P, Tacke F, Trautwein C, et al. Thrombopoietin serum levels are elevated in patients with hepatitis B/C infection compared to other causes of chronic liver disease [J]. Liver, 2002, 22(2) :114-120.
  • 7Garvey JS. Immunity and the red - blood cell[J]. Lancet, 1982, (1):223 - 227.
  • 8Shan H, Gupta RK, Golub S H, et al. Identification of a natural killer enhancing factor(NKEF) from human erythroid cell [ J ]. Cell immunol,1993,147(1): 1 - 7.
  • 9Sadallahg S, Giostro E, Mentha G, et al. increased level of soluble complement receptor in serum patients with liver disease[ J]. Hepatology,1996, 24(10) :118 - 122.
  • 10Di Bona, Motalto G, Clemenza L, et al, soluble complement receptor type 1 (scr1) in cirrhosis liver disease:serum level at different stages of liver diseases[J]. Clin Exp Immunol, 1998, 114(1):102- 105.

共引文献48

同被引文献16

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部